Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Nano-X Imaging Ltd.

NNOXNASDAQ
Healthcare
Medical - Devices
$2.37
$-0.06(-2.47%)
U.S. Market opens in 16h 8m

Nano-X Imaging Ltd. Fundamental Analysis

Nano-X Imaging Ltd. (NNOX) shows moderate financial fundamentals with a PE ratio of -2.79, profit margin of -4.53%, and ROE of -32.46%. The company generates $0.0B in annual revenue with strong year-over-year growth of 13.91%.

Key Strengths

Cash Position29.64%
PEG Ratio-1.25
Current Ratio4.14

Areas of Concern

ROE-32.46%
Operating Margin-4.70%
We analyze NNOX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -329.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-329.8/100

We analyze NNOX's fundamental strength across five key dimensions:

Efficiency Score

Weak

NNOX struggles to generate sufficient returns from assets.

ROA > 10%
-31.64%

Valuation Score

Excellent

NNOX trades at attractive valuation levels.

PE < 25
-2.79
PEG Ratio < 2
-1.25

Growth Score

Excellent

NNOX delivers strong and consistent growth momentum.

Revenue Growth > 5%
13.91%
EPS Growth > 10%
15.74%

Financial Health Score

Excellent

NNOX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
4.14

Profitability Score

Weak

NNOX struggles to sustain strong margins.

ROE > 15%
-3245.56%
Net Margin ≥ 15%
-4.53%
Positive Free Cash Flow
No

Key Financial Metrics

Is NNOX Expensive or Cheap?

P/E Ratio

NNOX trades at -2.79 times earnings. This suggests potential undervaluation.

-2.79

PEG Ratio

When adjusting for growth, NNOX's PEG of -1.25 indicates potential undervaluation.

-1.25

Price to Book

The market values Nano-X Imaging Ltd. at 0.99 times its book value. This may indicate undervaluation.

0.99

EV/EBITDA

Enterprise value stands at -4.28 times EBITDA. This is generally considered low.

-4.28

How Well Does NNOX Make Money?

Net Profit Margin

For every $100 in sales, Nano-X Imaging Ltd. keeps $-4.53 as profit after all expenses.

-4.53%

Operating Margin

Core operations generate -4.70 in profit for every $100 in revenue, before interest and taxes.

-4.70%

ROE

Management delivers $-32.46 in profit for every $100 of shareholder equity.

-32.46%

ROA

Nano-X Imaging Ltd. generates $-31.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

-31.64%

Following the Money - Real Cash Generation

Operating Cash Flow

Nano-X Imaging Ltd. generates limited operating cash flow of $-41.83M, signaling weaker underlying cash strength.

$-41.83M

Free Cash Flow

Nano-X Imaging Ltd. generates weak or negative free cash flow of $-46.29M, restricting financial flexibility.

$-46.29M

FCF Per Share

Each share generates $-0.73 in free cash annually.

$-0.73

FCF Yield

NNOX converts -30.20% of its market value into free cash.

-30.20%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.25

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

12.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.32

vs 25 benchmark

ROA

Return on assets percentage

-0.32

vs 25 benchmark

ROCE

Return on capital employed

-0.35

vs 25 benchmark

How NNOX Stacks Against Its Sector Peers

MetricNNOX ValueSector AveragePerformance
P/E Ratio-2.7929.43 Better (Cheaper)
ROE-32.46%800.00% Weak
Net Margin-452.82%-20145.00% (disorted) Weak
Debt/Equity0.050.30 Strong (Low Leverage)
Current Ratio4.144.64 Strong Liquidity
ROA-31.64%-17936.00% (disorted) Weak

NNOX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nano-X Imaging Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-85.03%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-416.67%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ